Autonomix Medical, Inc.
AMIX- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001617867
No open-market purchases or sales by Autonomix Medical, Inc. insiders were filed in the last 90 days; 6 institutions reported holding it in 13F filings for Q2 2026, worth $30.3K in total; no superinvestor holds it.
13F holders, Q1 2025
Institutional positions in Autonomix Medical, Inc. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 13
- 0 vs. Q4 2024
- Shares held
- 154.1K
- −59.5K (−27.8%) vs. Q4 2024
- Total value
- $144.2K
- −$332.4K (−69.7%) vs. Q4 2024
- New holders
- 1
- 3 more added
- Sold out
- 1
- 3 more reduced
1 institution that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting AMIX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 6 | $30.3K |
| Q1 2026 | 15 | $144.8K |
| Q4 2025 | 17 | $91.0K |
| Q3 2025 | 19 | $172.2K |
| Q2 2025 | 20 | $173.2K |
| Q1 2025 | 13 | $144.2K |
| Q4 2024 | 14 | $476.6K |
| Q3 2024 | 18 | $221.3K |
| Q2 2024 | 16 | $88.9K |
| Q1 2024 | 10 | $100.0K |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2025
Shares, value and share of portfolio for each institution holding Autonomix Medical, Inc.; share changes are against Q4 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Mariner, LLC | 100,643 | $50.6K | 0.00% | +250.0% | Added |
| Ikarian Capital, LLC | 20,000 | $35.0K | 0.01% | 00.0% | Unchanged |
| UBS Group AG | 15,941 | $27.9K | 0.00% | −24,547−60.6% | Reduced |
| Citadel Advisors LLC | 11,719 | $20.5K | 0.00% | −36,165−75.5% | Reduced |
| Tower Research Capital LLC (TRC) | 2,169 | $3.80K | 0.00% | +1,249+135.8% | Added |
| The PNC Financial Services Group, Inc. | 1,838 | $3.22K | 0.00% | 00.0% | Unchanged |
| BlackRock, Inc. | 1,738 | $3.04K | 0.00% | −33−1.9% | Reduced |
| Investors Research Corp | 20 | $35 | 0.00% | 00.0% | Unchanged |
| Harbour Investments, Inc. | 10 | $18 | 0.00% | 00.0% | Unchanged |
| SWAN Capital LLC | 10 | $18 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 10 | $17 | 0.00% | +10 | New |
| Bank of America Corp | 9 | $16 | 0.00% | +4+80.0% | Added |
| National Bank of Canada | 7 | $12 | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 0 | $0 | 0.00% | −7−100.0% | Sold out |
| Global Retirement Partners, LLC | – | – | – | – | Not filed |